This is not the most recent version of the article. View current version (4 APR 2017)

Intervention Review

Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke

  1. Peter AG Sandercock1,*,
  2. Carl Counsell2,
  3. Mei-Chiun Tseng3

Editorial Group: Cochrane Stroke Group

Published Online: 16 JUL 2008

DOI: 10.1002/14651858.CD000119.pub3


How to Cite

Sandercock PAG, Counsell C, Tseng MC. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke. Cochrane Database of Systematic Reviews 2008, Issue 3. Art. No.: CD000119. DOI: 10.1002/14651858.CD000119.pub3.

Author Information

  1. 1

    University of Edinburgh, Division of Clinical Neurosciences, Edinburgh, UK

  2. 2

    University of Aberdeen, Division of Applied Health Sciences, Aberdeen, UK

  3. 3

    National Sun Yat-Sen University, Department of Business Management, Kaohsiung, Taiwan, China

*Peter AG Sandercock, Division of Clinical Neurosciences, University of Edinburgh, Neurosciences Trials Unit, Bramwell Dott Building, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU, UK. peter.sandercock@ed.ac.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions), comment added to review
  2. Published Online: 16 JUL 2008

SEARCH

This is not the most recent version of the article. View current version (04 APR 2017)

  1. Current Version

    Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke

    Peter AG Sandercock and Tze Shin Leong

    Version of Record online: 4 APR 2017 | DOI: 10.1002/14651858.CD000119.pub4

Previous versions of this article and their online publication dates

  1. Version 3

    Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke

    Peter AG Sandercock, Carl Counsell and Mei-Chiun Tseng

    Version of Record online: 16 JUL 2008 | DOI: 10.1002/14651858.CD000119.pub3